How Gilead, Which Just Hit A Record, Notched Its Best Sales Growth In A Decade

Gilead Sciences crushed Wall Street's sales expectations on the back of its HIV treatments and cancer drug Trodelvy. The post How Gilead, Which Just Hit A Record, Notched Its Best Sales Growth In A Decade appeared first on Investor's Business Daily.

CryptoAlerta — análise de criptomoedas e mercado em tempo real